Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence score as an exemplar.
暂无分享,去创建一个
R. Street | C. Isaacs | S. Vadaparampil | S. O’Neill | S. Eggly | J. Jayasekera | B. Augusto | H. Han | Katherine Lopez | Matilda Brilleman | Jennifer D. Garcia | J. Garcia | Tanina F Moore | T. F. Moore | Bianca M. Augusto
[1] R. Street,et al. Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes. , 2020, JCO oncology practice.
[2] T. Albrecht,et al. The influence of a question prompt list on patient-oncologist information exchange in an African-American population. , 2020, Patient education and counseling.
[3] M. Somerfield,et al. Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Virginia G Kaklamani,et al. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. , 2019, The New England journal of medicine.
[5] Fabrice Andre,et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Hilsenbeck,et al. Exome sequencing disclosures in pediatric cancer care: Patterns of communication among oncologists, genetic counselors, and parents. , 2018, Patient education and counseling.
[7] V. Montori,et al. Comparison of audio vs. audio + video for the rating of shared decision making in oncology using the observer OPTION5 instrument: an exploratory analysis , 2018, BMC Health Services Research.
[8] Virginia G Kaklamani,et al. Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer , 2018, The New England journal of medicine.
[9] A. Coulter,et al. Lessons in Integrating Shared Decision-Making Into Cancer Care. , 2018, Journal of oncology practice.
[10] Jonathan M Marron,et al. Intended and unintended consequences: Ethics, communication, and prognostic disclosure in pediatric oncology , 2018, Cancer.
[11] G. Elwyn,et al. An evaluation of two interventions to enhance patient-physician communication using the observer OPTION5 measure of shared decision making. , 2017, Patient education and counseling.
[12] R. Epstein,et al. Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Ian Krop,et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Griggs,et al. Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists. , 2017, Patient education and counseling.
[15] A. Gustafson. Reducing Patient Uncertainty: Implementation of a shared decision‐making process enhances treatment quality and provider communication , 2017, Clinical journal of oncology nursing.
[16] R. Bast,et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] G. Elwyn,et al. Implementing shared decision-making: consider all the consequences , 2015, Implementation Science.
[18] G. Lyman,et al. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009. , 2015, JAMA oncology.
[19] C. Isaacs,et al. Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.
[20] PhD Zackary Berger MD,et al. Navigating the Unknown: Shared Decision-Making in the Face of Uncertainty , 2015, Journal of General Internal Medicine.
[21] L. Enewold,et al. Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy , 2015, Breast Cancer Research and Treatment.
[22] P. Butow,et al. The characteristics and effectiveness of Question Prompt List interventions in oncology: a systematic review of the literature , 2015, Psycho-oncology.
[23] L. Squiers,et al. Implementing and evaluating shared decision making in oncology practice , 2014, CA: a cancer journal for clinicians.
[24] R. Kravitz,et al. A pathway linking patient participation in cancer consultations to pain control , 2014, Psycho-oncology.
[25] Glyn Elwyn,et al. Using a 'talk' model of shared decision making to propose an observation-based measure: Observer OPTION 5 Item. , 2013, Patient education and counseling.
[26] K. Nordin,et al. Changes in health‐related quality of life by occupational status among women diagnosed with breast cancer—a population‐based cohort study , 2013, Psycho-oncology.
[27] H. Witteman,et al. Shared decision making: examining key elements and barriers to adoption into routine clinical practice. , 2013, Health affairs.
[28] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[29] C. Isaacs,et al. Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS , 2012, Journal of Cancer Epidemiology.
[30] M. Sprangers,et al. Postoperative information needs and communication barriers of esophageal cancer patients. , 2012, Patient education and counseling.
[31] R. Thomson,et al. Shared Decision Making: A Model for Clinical Practice , 2012, Journal of General Internal Medicine.
[32] Paul K. J. Han,et al. Varieties of Uncertainty in Health Care , 2011 .
[33] P. Ganz,et al. Physical and psychosocial recovery in the year after primary treatment of breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] A. Jemal,et al. Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[35] X. Shu,et al. Quality of life after breast cancer diagnosis and survival. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Paul K J Han,et al. Varieties of uncertainty in health care: a conceptual taxonomy. , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[37] A. Coulter,et al. Implementing shared decision making in the NHS , 2010, BMJ : British Medical Journal.
[38] L. Carey,et al. Women's experiences with genomic testing for breast cancer recurrence risk , 2010, Cancer.
[39] Richard L. Street,et al. Patient-centered communication in cancer care: Promoting healing and reducing suffering , 2007 .
[40] Richard L Street,et al. Physicians' communication and perceptions of patients: is it how they look, how they talk, or is it just the doctor? , 2007, Social science & medicine.
[41] J. Hornberger,et al. Impact of a 21‐gene RT‐PCR assay on treatment decisions in early‐stage breast cancer , 2007, Cancer.
[42] Gregory Makoul,et al. An integrative model of shared decision making in medical encounters. , 2006, Patient education and counseling.
[43] Peter Watson,et al. Do patients benefit from participating in medical decision making? Longitudinal follow‐up of women with breast cancer , 2006, Psycho-oncology.
[44] Gary H Lyman,et al. Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer. , 2005, The American journal of managed care.
[45] J. Lowery,et al. Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] A. Ashworth,et al. Molecular profiling of breast cancer: clinical implications , 2004, British Journal of Cancer.
[47] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[48] B. Hillner. Impact of a 21-Gene RT-PCR Assay on Treatment Decisions in Early-Stage Breast Cancer , 2008 .